1931 — IVD Medical Holding Income Statement
0.000.00%
Last trade - 00:00
- HK$3.10bn
- HK$2.21bn
- CNY3.09bn
- 84
- 78
- 62
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,333 | 2,428 | 2,731 | 2,749 | 3,088 |
Cost of Revenue | |||||
Gross Profit | 443 | 476 | 566 | 608 | 672 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,030 | 2,178 | 2,464 | 2,423 | 2,686 |
Operating Profit | 303 | 250 | 267 | 326 | 403 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 297 | 232 | 268 | 284 | 339 |
Provision for Income Taxes | |||||
Net Income After Taxes | 255 | 155 | 162 | 196 | 237 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 275 | 159 | 175 | 210 | 238 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 245 | 159 | 175 | 210 | 238 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.271 | 0.119 | 0.137 | 0.165 | 0.177 |
Dividends per Share |